Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated &lt;i&gt;SOD1&lt;/i&gt;-ALS: A Real-World Multicentre Cohort Study. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.